AK: Alasca / AL: Alabama
AR: Arkansas
AZ: Arizona
CA: Califórnia
CO: Colorado
CT: Connecticut
DE: Delaware
FL: Flórida
GA: Geórgia
HI: Havaí
IA: Iowa
ID: Idaho
IL: Illinois
IN: Indiana
KS: Kansas
KY: Kentucky
LA: Louisiana
MA: Massachusetts
MD: Maryland
ME: Maine
MI: Michigan
MN: Minnesota
MO: Missouri
MS: Mississippi
MT: Montana
NC: Carolina do Norte
ND: Dakota do Norte
NE: Nebraska
NH: Nova Hampshire
NJ: Nova Jérsei
NM: Novo México
NV: Nevada
NY: Nova Iorque
OH: Ohio
OK: Oklahoma
OR: Oregon
PA: Pensilvânia
RI: Rhode Island
SC: Carolina do Sul
SD: Dakota do Sul
TN: Tennessee
TX: Texas
UT: Utah
VT: Vermont
VA: Virgínia
WA: Washington
WI: Wisconsin
WV: Virgínia Ocidental
WY: Wyoming

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

ATIVESITE | Stephanie, Atteinte de PHA

This video is intended for CEMEA audiences. La PHA est une maladie chronique et invalidante qui a un impact néfaste sur la qualité de vie des patients et de leur…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | JIŘÍ, ŽIVOT S AHP

This video is intended for CEMEA audiences. Já neudělám prostě to, co udělá zdravý člověk. Zdravý člověk udělá tu práci za hodinu. Já to dělám třeba dva dny. A jsem…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | RNAi Therapeutics – How this New Class of Medicines Works

This video was created for UK and Irish audiences. Alnylam is the world’s leading RNA interference (RNAi) company and has pioneered the 2006 Nobel Prize-winning discovery of RNAi into an…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | Verónica, vivir con PAH

This video is approved for CEMEA audiences. Para una persona que acaba de ser diagnosticada de porfiria aguda intermitente, mi mensaje sería que no se venga abajo, que no desespere.…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | Eva, Lebt Mit AHP

This video is intended for CEMEA audiences. AHP ist eine chronische Erkrankung, die das Leben der Patienten und ihrer Angehörigen stark belasten kann. Hören Sie von Eva, wie bei ihr…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | Seth – Living with Primary Hyperoxaluria Type 1 (PH1)

This video is created for US audiences. In this video Seth, as a combined liver/kidney transplant recipient, discusses his experience with kidney failure and being diagnosed with primary hyperoxaluria type…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | International Porphyria Awareness Week PAG Perspectives: France

This video was created for US audiences. Sylvie Le Moal from the Association Française des Malades Atteints de Porphyrie discusses the importance of raising awareness of porphyria, a rare, often…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | Stephanie and Jorg’s PH1 story

This video was created for CEMEA audiences. Stephanie, from Germany, shares the story of her husband Jorg, who sadly passed away from Primary Hyperoxaluria Type 1 (PH1) in 2018. She…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | Johan, lever med AHP

This video is intended for CEMEA audiences. “När man har en akut attack av porfyri så har man så oerhört ont i hela magregionen och bröstkorgen. Det är svårt att…

Read More »
Alnylam Pharmaceuticals

ATIVESITE | International Porphyria Awareness Week PAG Perspectives: Germany

This video was created for US audiences. Dr. Thorsten Schweikardt from Selbsthilfe EPP e.V. and Sabine von Wegerer from Berliner Leberring e.V discuss the importance of raising awareness of porphyria,…

Read More »